Merck’s COVID pill works, but FDA must verify its safety is taken during pregnancy


Merck’s experimental COVID-19 antiviral pill is effective, but the Food and Drug Administration (FDA) says it has yet to be identified whether the drug is safe to take during pregnancy.

Merck’s experimental COVID-19 antiviral pill is effective, but the Food and Drug Administration (FDA) says it has yet to be identified whether the drug is safe to take during pregnancy.

Merck’s COVID-19 Antiviral Pill

Merck & Co. and Ridgeback Biotherapeutics LP said the experimental COVID-19 pill is 30% effective in their company’s final analysis. In addition, the FDA is reviewing the emergency authorization of the pill that could potentially lead to serious safety concerns, as scientists warned of the potential dangers and limit the use of the drug stated in a report.

The FDA said in an interview with The Associated Press on Friday that it had identified some potential risks, including toxicity and possible birth defects. In addition, the company agreed that it would not be advisable to use the drug in children and pregnant women. However, unless prescribed by doctors, as it might be beneficial to prescribe it in a certain scenario to outweigh the risks of pregnant patients. In addition, the clinical study shows that molnupiravir is remarkably less effective in reducing hospitalizations and deaths than previously reported by Reuters.

Effective Merck COVID pill

The drug, molnupiravir, has been shown to significantly reduce the rate of hospitalizations and death in people with mild to moderate COVID-19 infections. The company says the Merck pill has shown a 30% decrease in hospitalizations and deaths, based on details among 1,433 patients. As of last October, the data appears to be around 50% accurate, based on data from 775 patients.

The oral inhibitor drug combines the genetics of the virus which causes a high volume of mutations to kill the virus. But, some lab results indicate the drug’s ability to create mutations in the genetic material of mammalian cells, theoretically causing cancer or birth defects, Barron reported.


Comments are closed.